![Kevin Moulder](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profiel
Kevin Moulder served as the Chief Development Officer at Tusk Therapeutics Ltd. from 2015 to 2018.
He then worked as the Chief Operating Officer at Polyprox Therapeutics Ltd. from 2018 to 2021.
In 2021, he became the Chief Scientific Officer at Medicenna Therapeutics Corp.
Dr. Moulder also held the position of Chief Scientific Officer at F-star Therapeutics Ltd. Dr. Moulder received a graduate and doctorate degree from the University of London.
Eerdere bekende functies van Kevin Moulder
| Bedrijven | Functie | Einde |
|---|---|---|
| MEDICENNA THERAPEUTICS CORP. | Hoofd Techniek/Wetenschap/O&O | 03-03-2022 |
Polyprox Therapeutics Ltd.
 Polyprox Therapeutics Ltd. BiotechnologyHealth Technology Operates as biotechnology company which engages in research and development of drugs to treat cancer and neurodegenerative diseases | Operationeel Directeur | 01-02-2021 |
Tusk Therapeutics Ltd.
 Tusk Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | 01-09-2018 |
F-star Therapeutics Ltd.
 F-star Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops antibodies therapeutics for cancer therapy | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van Kevin Moulder
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
4
Eerstegraads connecties
5
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
University of London
 University of London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tusk Therapeutics Ltd.
Tusk Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Medicenna Therapeutics Corp.
 Medicenna Therapeutics Corp. BiotechnologyHealth Technology Develops biopharmaceuticals | Health Technology |
Polyprox Therapeutics Ltd.
Polyprox Therapeutics Ltd. BiotechnologyHealth Technology Operates as biotechnology company which engages in research and development of drugs to treat cancer and neurodegenerative diseases | Health Technology |
F-star Therapeutics Ltd.
F-star Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops antibodies therapeutics for cancer therapy | Health Technology |
